{"transactions":[{"id":813519,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-04-08T00:00:06.000Z","date":"2026-04-03","kind":"grant","planned":false,"acquired":true,"shares":946107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 946,107 shares of the Issuer's common stock (111,621 shares of which are underlying incentive stock options and 834,486 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 946,107 shares of the Issuer's common stock (111,621 shares of which are underlying incentive stock options and 834,486 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."}],"balance_after":946107,"derivative":{"exercise_price":0.98,"underlying":"Common Stock","underlying_shares":946107},"source":{"system":"sec-edgar","filing":"0001493152-26-015594","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315226015594/ownership.xml","form_type":"4"}},{"id":829448,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2026-03-25T01:16:41.000Z","date":"2026-03-20","kind":"purchase","planned":false,"acquired":true,"shares":12150,"ownership":{"direct":false,"nature":"The Bagai Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased in a private placement on March 20, 2026 for an aggregate of $25,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report."}],"balance_after":12150,"derivative":{"exercise_price":1.9326,"underlying":"Common Stock","underlying_shares":12150},"source":{"system":"sec-edgar","filing":"0001493152-26-012482","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315226012482/ownership.xml","form_type":"4"}},{"id":829447,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-25T01:16:41.000Z","date":"2026-03-20","kind":"purchase","planned":false,"acquired":true,"shares":24300,"ownership":{"direct":false,"nature":"The Bagai Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased in a private placement on March 20, 2026 for an aggregate of $25,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"289,057 shares of common stock are held of record by The Bagai Family Trust and were previously reported as \"directly\" beneficially held by the Reporting Person."}],"balance_after":313357,"source":{"system":"sec-edgar","filing":"0001493152-26-012482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315226012482/ownership.xml","form_type":"4"}},{"id":961107,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:00:23.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9013,"value":4506.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":340040,"source":{"system":"sec-edgar","filing":"0001493152-25-028650","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315225028650/ownership.xml","form_type":"4"}},{"id":962122,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-19T12:00:20.000Z","date":"2025-12-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.8524,"value":4262.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":335040,"source":{"system":"sec-edgar","filing":"0001493152-25-028439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315225028439/ownership.xml","form_type":"4"}},{"id":1055841,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-26T10:10:14.000Z","date":"2025-08-25","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9098,"value":4549.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":330040,"source":{"system":"sec-edgar","filing":"0001641172-25-025459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225025459/ownership.xml","form_type":"4"}},{"id":1055840,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-26T10:10:14.000Z","date":"2025-08-22","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9495,"value":4747.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":325040,"source":{"system":"sec-edgar","filing":"0001641172-25-025459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225025459/ownership.xml","form_type":"4"}},{"id":1092687,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-07-03T20:45:33.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":102498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 21,072 incentive stock options and 81,426 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of 21,072 incentive stock options and 81,426 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025."}],"balance_after":102498,"derivative":{"exercise_price":1.27,"underlying":"Common Stock","underlying_shares":102498},"source":{"system":"sec-edgar","filing":"0001641172-25-017832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225017832/ownership.xml","form_type":"4"}},{"id":1171070,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-04-16T21:18:21.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":409992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 409,992 shares of the Issuer's common stock (187,812 shares of which are underlying incentive stock options and 222,180 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 409,992 shares of the Issuer's common stock (187,812 shares of which are underlying incentive stock options and 222,180 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035."}],"balance_after":409992,"derivative":{"exercise_price":0.8448,"underlying":"Common Stock","underlying_shares":409992},"source":{"system":"sec-edgar","filing":"0001641172-25-005107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225005107/ownership.xml","form_type":"4"}},{"id":1171069,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-16T10:08:22.000Z","date":"2025-04-15","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":0.9095,"value":6821.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":320040,"source":{"system":"sec-edgar","filing":"0001641172-25-004955","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225004955/ownership.xml","form_type":"4"}},{"id":1174146,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-10T10:02:18.000Z","date":"2025-04-09","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.83,"value":8300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.82795 to $0.829, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":312540,"source":{"system":"sec-edgar","filing":"0001641172-25-003504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225003504/ownership.xml","form_type":"4"}},{"id":1175713,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-08T15:30:03.000Z","date":"2025-04-07","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.83,"value":8300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.816 to $0.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":302540,"source":{"system":"sec-edgar","filing":"0001641172-25-003158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225003158/ownership.xml","form_type":"4"}},{"id":1666707,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2024-01-30T23:57:58.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":40983,"derivative":{"exercise_price":1.22,"underlying":"Common Stock","underlying_shares":40983},"source":{"system":"sec-edgar","filing":"0001493152-24-004368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315224004368/ownership.xml","form_type":"4"}},{"id":1666706,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-30T23:57:58.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":292540,"source":{"system":"sec-edgar","filing":"0001493152-24-004368","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315224004368/ownership.xml","form_type":"4"}},{"id":1673194,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-01-24T02:50:23.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":250263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 19, 2024, the Reporting Person received a nonqualified stock option grant for a total of 250,263 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 19, 2024, the Reporting Person received a nonqualified stock option grant for a total of 250,263 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034."}],"balance_after":250263,"derivative":{"exercise_price":1.08,"underlying":"Common Stock","underlying_shares":250263},"source":{"system":"sec-edgar","filing":"0001493152-24-003521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315224003521/ownership.xml","form_type":"4"}},{"id":1673193,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-01-24T02:50:23.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":66973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 19, 2024, the Reporting Person was awarded a stock bonus of 66,973 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the \"Plan\"). These shares were fully vested upon issuance to the Reporting Person, expires on January 19, 2034."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 19, 2024, the Reporting Person was awarded a stock bonus of 66,973 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the \"Plan\"). These shares were fully vested upon issuance to the Reporting Person, expires on January 19, 2034."}],"balance_after":66973,"derivative":{"exercise_price":1.08,"underlying":"Common Stock","underlying_shares":66973},"source":{"system":"sec-edgar","filing":"0001493152-24-003521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315224003521/ownership.xml","form_type":"4"}},{"id":1935865,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-29T20:55:52.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments beginning on January 1, 2023."}],"balance_after":130000,"derivative":{"exercise_price":3.29,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001493152-23-009494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315223009494/ownership.xml","form_type":"4"}},{"id":2260275,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-23T10:09:42.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":5500,"price":2.05,"value":11275.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 246,057 shares previously reported on a Form 3 filed on August 25, 2021 as a fully vested stock option exercisable at $0.15 per share. The option was exercised in full prior to the Issuer's initial public offering."}],"balance_after":251557,"source":{"system":"sec-edgar","filing":"0001209191-22-031236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000120919122031236/doc4.xml","form_type":"4"}},{"id":2335746,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-14T20:12:43.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":48313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021."}],"balance_after":48313,"derivative":{"exercise_price":3.17,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":48313},"source":{"system":"sec-edgar","filing":"0001209191-22-018448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000120919122018448/doc4.xml","form_type":"4"}},{"id":2552385,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-10-05T00:07:02.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":117866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021."}],"balance_after":117866,"derivative":{"exercise_price":6.04,"expiration_date":"2031-09-29","underlying":"Common Stock","underlying_shares":117866},"source":{"system":"sec-edgar","filing":"0001209191-21-059159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000120919121059159/doc4.xml","form_type":"4"}}]}